Zymeworks: Partnerships and Licensing

Partnership and licensing opportunities from Zymeworks.

 

Partnership Title: Zymeworks is an industry leader in both multispecific antibody research and antibody drug conjugates

Our technology leverages Zymeworks’ industry leading expertise in the fields of protein engineering and drug chemistry to discover and develop the next generation of antibody-based therapeutics to combat unmet medical need in hard-to-treat cancers and other serious diseases.

The integration of complementary and antibody-based technologies, embedded in our proprietary Multispecific and Antibody-Drug Conjugate (ADC) therapeutic modalities, interfaced with disease biology, enables the development of differentiated and fit-for-purpose therapeutics.

• Licencing Out
  We offer our products to other companies on an 'out-licensing' basis.

• Research and Development
  We offer co-development opportunities.

• Biopharmaceuticals
  - Biopharmaceuticals-Discovery Platforms
  - Biopharmaceuticals-Technology

• Proprietary Formulations
  - Proprietary Formulations-Clinical Development

• Antineoplastic and Immunomodulating Agents
  - -Antineoplastic and Immunomodulating Products-General Group
  - Immuno-oncology

Claim This Profile

This is the Partnership and Licensing section of the company profile page for Zymeworks on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.